logo

For the Inventor, By the Inventor

Oslo, Norway

Optinose as


USPTO Granted Patents = 74

% Expired Patents = 27.0



Trademarks = 6

Forward Citations = 3,456

Loading Chart...
Loading Chart...

32 inventors (with patents filed for the assignee):

goldMedal Per Gisle Djupesland (71 out of 80 patents)

silverMedal Colin David Sheldrake (14 out of 19 patents)

bronzeMedal Roderick Peter Hafner (12 out of 29 patents)

4.  Ramy A Mahmoud (7 out of 11 patents)

5.  Michael E Leclerc (6 out of 48 patents)

6.  Joseph M Gordon (6 out of 65 patents)

7.  Shane Siwinski (5 out of 17 patents)

8.  Justin Fisk (4 out of 47 patents)

9.  Rune Harald Gaarder (3 out of 3 patents)

10.  Stuart Brian William Kay (3 out of 20 patents)

11.  Kate Dudgeon (3 out of 3 patents)

12.  Martin Joseph Murphy (3 out of 3 patents)

13.  Andrew Gordon Pocock (3 out of 19 patents)

14.  Mark Joseph Guarraia (3 out of 75 patents)

15.  Simon James Smith (2 out of 26 patents)


Core Competencies:
Nasal Delivery
Intranasal Administration
Nasal Devices
Delivery Devices
Powder Delivery
Breath-Actuated
Oxytocin Delivery
Nosepiece Unit
Airway Gases
Delivery Method
Nasal Administration
Device Apparatus

74 patents:

1. 11291626 - Nasal delivery of oxytocin (2022-04-05),
2. 11083858 - Nasal delivery devices (2021-08-10),
3. 11052204 - Intranasal administration (2021-07-06),
4. 11033696 - Nasal delivery devices (2021-06-15),
5. 10940277 - Intranasal administration (2021-03-09),
6. 10864334 - Nasal delivery (2020-12-15),
7. 10765829 - Delivery of gases to the nasal airway (2020-09-08),
8. 10737045 - Delivery devices (2020-08-11),
9. 10722667 - Nasal administration (2020-07-28),
10. 10639438 - Delivery devices (2020-05-05),
11. 10639437 - Delivery devices (2020-05-05),
12. 10525218 - Nasal delivery devices (2020-01-07),
13. 10478574 - Nasal administration (2019-11-19),
14. 10398859 - Nasal delivery devices (2019-09-03),
15. 10300229 - Nasal delivery devices (2019-05-28),
OptiNose AS is a pharmaceutical company that specializes in innovative nasal drug delivery solutions. We develop and commercialize products that optimize the treatment of medical conditions through the nose. Our patented technology, called Exhalation Delivery System (EDS), enables targeted drug delivery deep into the nasal cavity, providing improved efficacy and patient convenience. At OptiNose, we aim to improve the lives of patients by advancing the science of nasal drug delivery and providing innovative treatment options.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Optinose as
74 Patents

#9 in Oslo

#20 in Norway

#10,111 in the World

Oslo, NO
Oslo, Norway

Optinose as

Forward Citations = 3,456

32 inventors:

goldMedal Per Gisle Djupesland (71 out of 80 patents)

silverMedal Colin David Sheldrake (14 out of 19 patents)

bronzeMedal Roderick Peter Hafner (12 out of 29 patents)

4.  Ramy A Mahmoud (7 out of 11 patents)

5.  Michael E Leclerc (6 out of 48 patents)

Please report any incorrect information to [email protected]
Loading…